Rick E Winningham Theravance Biopharma, Inc. (TBPH) insider trading activity

Rick E Winningham is CHIEF EXECUTIVE OFFICER of Theravance Biopharma, Inc.. Currently has a direct ownership of 1.73 Million shares of TBPH, which is worth approximately $19.3 Million. The most recent transaction as insider was on Jun 23, 2025, when has been sold 20,000 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.73M

2.53% 3M change

5.63% 12M change

Total Value Held $19.3 Million

Rick E Winningham Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 23 2025	SELL Bona fide gift	-	20,000 Reduced 1.14%	1,733,180 Ordinary Shares
Jun 13 2025	SELL Bona fide gift	-	9,600 Reduced 0.54%	1,753,180 Ordinary Shares
May 20 2025	SELL Payment of exercise price or tax liability	$145,189 $9.45 p/Share	15,364 Reduced 0.86%	1,762,780 Ordinary Shares
Feb 28 2025	BUY Grant, award, or other acquisition	$20,364 $9.35 p/Share	2,178 Added 0.12%	1,778,144 Ordinary Shares
Feb 20 2025	SELL Payment of exercise price or tax liability	$339,346 $9.66 p/Share	35,129 Reduced 1.94%	1,775,966 Ordinary Shares
Nov 20 2024	SELL Payment of exercise price or tax liability	$159,490 $9.97 p/Share	15,997 Reduced 0.88%	1,811,095 Ordinary Shares
Nov 14 2024	BUY Grant, award, or other acquisition	$30,557 $9.57 p/Share	3,193 Added 0.17%	1,827,092 Ordinary Shares
Aug 20 2024	SELL Payment of exercise price or tax liability	$131,495 $8.22 p/Share	15,997 Reduced 0.87%	1,823,899 Ordinary Shares
Aug 07 2024	BUY Grant, award, or other acquisition	$25,463 $7.83 p/Share	3,252 Added 0.18%	1,839,896 Ordinary Shares
May 20 2024	SELL Payment of exercise price or tax liability	$145,572 $9.1 p/Share	15,997 Reduced 0.86%	1,836,644 Ordinary Shares
May 15 2024	BUY Grant, award, or other acquisition	$20,369 $9.85 p/Share	2,068 Added 0.11%	1,852,641 Ordinary Shares
Apr 02 2024	BUY Grant, award, or other acquisition	-	300,000 Added 13.95%	1,850,573 Ordinary Shares
Mar 15 2024	SELL Bona fide gift	-	10,900 Reduced 0.7%	1,550,573 Ordinary Shares
Mar 15 2024	BUY Grant, award, or other acquisition	$23,362 $8.64 p/Share	2,704 Added 0.17%	1,561,473 Ordinary Shares
Feb 20 2024	SELL Payment of exercise price or tax liability	$331,788 $8.92 p/Share	37,196 Reduced 2.33%	1,558,769 Ordinary Shares
Nov 20 2023	SELL Payment of exercise price or tax liability	$163,887 $10.37 p/Share	15,804 Reduced 0.98%	1,595,965 Ordinary Shares
Aug 20 2023	SELL Payment of exercise price or tax liability	$153,298 $9.7 p/Share	15,804 Reduced 0.97%	1,611,769 Ordinary Shares
May 20 2023	SELL Payment of exercise price or tax liability	$177,162 $11.21 p/Share	15,804 Reduced 0.96%	1,627,573 Ordinary Shares
Mar 01 2023	BUY Grant, award, or other acquisition	-	330,000 Added 16.72%	1,643,377 Ordinary Shares
Feb 20 2023	SELL Payment of exercise price or tax liability	$390,664 $10.44 p/Share	37,420 Reduced 2.77%	1,313,377 Ordinary Shares
Dec 14 2022	SELL Open market or private sale	$559,500 $11.19 p/Share	50,000 Reduced 3.57%	1,350,797 Ordinary Shares
Dec 13 2022	SELL Bona fide gift	-	9,000 Reduced 0.64%	1,400,797 Ordinary Shares
Nov 20 2022	SELL Payment of exercise price or tax liability	$171,473 $10.85 p/Share	15,804 Reduced 1.11%	1,409,797 Ordinary Shares
Aug 19 2022	SELL Payment of exercise price or tax liability	$147,609 $9.34 p/Share	15,804 Reduced 1.1%	1,424,784 Ordinary Shares
May 20 2022	SELL Payment of exercise price or tax liability	$96,358 $8.74 p/Share	11,025 Reduced 0.76%	1,440,588 Ordinary Shares

Also insider at

JAZZ

Jazz Pharmaceuticals plc Healthcare

Director

REW